Wockhardt Limited is an Indian based company which is engaged in the business of manufacturing and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. It has approximately three research centers globally and 10 manufacturing plants located in India, the United Kingdom, Ireland and the United States.

Company’s products include Ace Proxyvon, Bio-Corneum, Aceroc, Alphadopa, Biovac Typhoid, Acetic Acid Otic Solution, Amlodipine Besylate Tablets, Adenosine Injection, Amoxicillin and Clavulanate Potassium for Oral Suspension, Azithromycin Tablets, Aciclovir Powder for Injection, Alendronic Acid, Amitriptyline, Clarithromycin, Entacapone Tablet and Flucloxacillin Injection. It operates a chain of approximately 10 super specialty hospitals, which offer treatment and care facilities in cardiology, neurosurgery, orthopedics, critical care, oncology, nephrology, urology and others.


Wockhardt ResultsBSE Code : 532300
NSE Symbol : WOCKPHARMA
ISIN No. : INE049B01025
Industry : Pharmaceuticals
Face Value : Rs. 5.00


If you are an investor who has shares of Wockhardt or you are an stock market analyst then i am sure you might for Quarterly Results of Wockhardt.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Wockhardt. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Wockhardt.

Wockhardt Q1 Results 2016-17 :

Wockhardt will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Wockhardt will announce its Q2 FY 2016-17 Results in the month of October 2016.

Wockhardt will announce its Q3 FY 2016-17 Results in the month of January 2017.

Wockhardt will announce its Q4 FY 2016-17 Results in the month of April 2017.

Wockhardt will announce its FY 2016-17 Results in the month of April 2017.

Note : We will update the results table above as and when results are announced. Visit again.

Wockhardt Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue 2224.74 4461.43
Other Income  49.96  82.53
Total Income  2274.70  4543.96
Expenditure  -2089.79  -4085.74
Interest  -79.95  -101.21
Depreciation  -101.75  -142.56
PBT  3.21  357.01
Tax  29.58  -25.48
Net Profit  32.79  331.53
Equity  55.25  55.25
EPS  2.97 29.50

Note : If you like this information about Wockhardt Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.